Pharmaceutical giant Kalbe Farma (KLBF) opened lower at Rp1735 this morning. At this price, Kalbe has market capitalization of Rp81.33 trillion or about US$7.1 billion. This company is among few companies in Indonesia consistently reporting return on equity (ROE) above 30% and contributing to the country’s high medical costs.
To subscribe please click here